NCT02914496View on ClinicalTrials.gov

ACT Stress Management in Type 1 Diabetes

NAActive, not recruitingINTERVENTIONAL
Enrollment

81

Participants

Timeline

Start Date

October 15, 2016

Primary Completion Date

June 30, 2020

Study Completion Date

December 31, 2025

Conditions
Type 1 Diabetes
Interventions
BEHAVIORAL

Acceptance and Commitment Therapy (ACT)

ACT is a specific form of Cognitive behavior therapy (CBT) which will be given as a course consisting of seven sessions where each session is two hours long.

Trial Locations (1)

11691

Ersta sjukhus, Stockholm

All Listed Sponsors
lead

Karolinska Institutet

OTHER

NCT02914496 - ACT Stress Management in Type 1 Diabetes | Biotech Hunter | Biotech Hunter